Fujifilm Medical Systems USA has issued a letter to its customers notifying them that four versions of its Synapse PACS software are in need of a patch to correct a problem that could affect patient image data, according to the U.S. Food and Drug Administration (FDA).
On September 15, Fujifilm notified its customers that Synapse software versions 4.0, 4.1, 4.2, and 4.3 may not produce correct image data and offered a patch that will fix it, according to the FDA notice. Customers with version 4.0 may upgrade to version 4.4 (which will not require the fix), or they may upgrade to versions 4.1, 4.2, or 4.3 and install the patch.
For sites that use Fujifilm's Active Monitoring service, the company will implement the patch on the server remotely; for sites not using Active Monitoring, it will schedule a time to do so, according to the FDA.
Synapse customers may contact Fujifilm at 1-888-FUJIMED with questions or concerns.
